NCT02809443View on ClinicalTrials.gov

GLS-5700 in Dengue Virus-Naïve Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

November 30, 2017

Study Completion Date

December 31, 2017

Conditions
Healthy
Interventions
BIOLOGICAL

GLS-5700

GLS-5700 contains a single plasmid containing DNA encoding for pre-membrane and envelope (prME) proteins of the Zika virus

Trial Locations (3)

19104

University of Pennslyvania, Philadelphia

33143

Miami Research Associate, Miami

Unknown

CHU de Québec -Université Laval hopital CHUL Centre de Recherche en infectiologie, Québec

Sponsors

Collaborators (1)

Inovio Pharmaceuticals
All Listed Sponsors
collaborator

Inovio Pharmaceuticals

INDUSTRY

lead

GeneOne Life Science, Inc.

INDUSTRY

NCT02809443 - GLS-5700 in Dengue Virus-Naïve Adults | Biotech Hunter | Biotech Hunter